Maverick Ventures is a venture capital firm based in San Francisco, California, founded in 2015. As the venture arm of Maverick Capital, it specializes in providing growth capital primarily in the healthcare, technology, and consumer sectors. In healthcare, the firm focuses on software and services, medical devices, tools and diagnostics, and biotechnology and pharmaceuticals. In the technology and consumer sectors, Maverick Ventures emphasizes investments in online, mobile, and offline-first companies. With a team that combines over 30 years of early-stage investment experience, Maverick Ventures has funded more than 100 companies and actively engages with entrepreneurs from seed funding through to maturation, often leading investment rounds and participating on boards to help build successful enterprises.
Daymark Health is a value-based oncology company redefining the cancer care experience for patients, providers, and health plans.
AheadComputing
Seed Round in 2025
AheadComputing is a company that specializes in designing, licensing, and providing support for high-performance microprocessor cores and related technologies.
Aligned Marketplace
Seed Round in 2025
Aligned Marketplace operates as a personalized primary care for workforce.
TensorWave
Venture Round in 2024
TensorWave enables enterprises to harness the power of artificial intelligence and create innovative AI-based software.
Daffodil Health
Seed Round in 2024
Daffodil Health is a pediatric behavioral health platform focused on supporting special needs children and their families. The company provides multi-modal therapies and real-time assistance tailored to the unique challenges faced by neurodiverse children. Its platform features a questionnaire designed for parents who observe developmental difficulties in their children. After analyzing the responses, Daffodil Health offers a free online consultation to discuss the concerns and develop an appropriate program. This approach empowers parents to actively participate in their child's therapeutic journey, equipping them with the tools and guidance needed to navigate the complexities of their child's needs.
Chapter
Series C in 2024
Chapter operates a Medicare navigation platform designed to assist seniors in selecting appropriate health coverage. The platform provides advisory services that ensure consumers receive the best coverage options tailored to their individual needs at the most affordable prices. By aligning the incentives of Medicare advisors and consumers, Chapter promotes unbiased recommendations that consider all available options, free from economic conflicts of interest. Additionally, the company offers retirees personalized resources such as tailored coupons, tax advice, and technology tips, enhancing their ability to live securely and purposefully as they age.
Thintronics
Series A in 2024
Thintronics is a Consumer Electronics company.
Clarity Pediatrics
Seed Round in 2024
Clarity Pediatrics is focused on transforming pediatric chronic care, particularly for children diagnosed with Attention-deficit/hyperactivity disorder (ADHD), which affects nearly 10% of American children. The company has developed a virtual pediatric ADHD clinic that utilizes a tech-enabled platform to deliver high-quality care to families. This platform includes features such as video conferencing, secure messaging, and electronic health records, allowing for accessible and efficient communication. Clarity Pediatrics aims to provide trusted care that is backed by scientific research, with the goal of achieving exceptional health outcomes that can significantly improve a child's developmental trajectory. By leveraging technology, the clinic seeks to reach a broader market of families, irrespective of their location or insurance status, ensuring that children receive the necessary support and resources.
Auradine
Series B in 2024
Auradine is a provider of web infrastructure solutions that focuses on blockchain, security, and privacy. The company offers a comprehensive range of services, including software, hardware, and cloud solutions designed to deliver scalable, sustainable, and secure infrastructure. With a strong background in security, software-as-a-service, semiconductors, and systems, Auradine aims to create innovative technologies that empower clients to adopt disruptive infrastructure. By integrating cutting-edge advancements in artificial intelligence, Auradine seeks to enhance its offerings and support businesses in navigating the evolving digital landscape.
Aligned Marketplace
Seed Round in 2024
Aligned Marketplace operates as a personalized primary care for workforce.
Nourish
Series A in 2024
Nourish is improving people’s health by making it easy to eat well. We provide clinical-grade nutrition care powered by a virtual network of registered dietitians, all covered by health insurance.
BlueFlag Security
Seed Round in 2024
BlueFlag Security provides a multi-layered defense platform that combines identity security, open-source software risk management, and developer tool posture management.
Oula Health
Series B in 2024
Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.
Areteia Therapeutics
Series A in 2024
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication of improving lung function and is found in several asthma-related treatments.
Silicon Box
Series B in 2024
Silicon Box is an advanced provider of outsourced semiconductor assembly and testing services, focusing on semiconductor integration. The company offers comprehensive capabilities in semiconductor packaging, from initial design to the final manufacturing of various chip types, including standard single chip packages and sophisticated chiplet-based systems. Its services support a wide range of applications, such as artificial intelligence, high-performance computing, electric vehicles, automotive technologies, power management, and mobile chipsets. Silicon Box aims to enhance chipset design through its manufacturing processes, which help shorten design cycles, reduce costs, and lower power consumption, ultimately delivering advanced and high-quality semiconductor interconnections to its customers.
Devoted
Series E in 2023
Devoted Health is a healthcare company focused on enhancing the health and well-being of older Americans by treating each individual with care and compassion. The company offers an integrated healthcare solution that includes Medicare Advantage plans, access to local providers, and the option for virtual and in-home care through Devoted Medical. Their approach includes personalized medical plans and dedicated guides who work closely with physicians to streamline care and minimize unnecessary procedures. By leveraging advanced technology and a robust network of healthcare professionals, Devoted Health aims to provide high-quality, tailored healthcare services to its members.
Spear Bio
Seed Round in 2023
Spear Bio is a biotechnology company established in 2021 and located in Weston, Massachusetts. The company specializes in ultrasensitive protein detection technology, which provides significant advantages in the healthcare sector. Its innovations support self-testing and telemedicine-based diagnostics by enabling the quantification of minute protein biomarkers from samples collected at home. This approach allows clinicians to achieve ultrasensitive detection using small sample volumes, seamlessly integrating into existing workflows for sample collection, processing, and analysis.
Tenstorrent
Venture Round in 2023
Tenstorrent Inc. is a Canadian company that develops and manufactures application-specific integrated circuits (ASIC) focused on artificial intelligence and machine learning. Founded in 2016 and headquartered in Toronto, with an additional office in Austin, Texas, Tenstorrent specializes in providing scalable and efficient hardware solutions for various applications, ranging from battery-powered Internet of Things (IoT) devices to large cloud servers. The company’s architecture supports deep learning and enables adaptability in algorithms, catering to developers and researchers in the technology sector. By offering advanced AI hardware and software, Tenstorrent aims to enhance computational performance and facilitate the growth of machine learning technologies.
Gather Health
Series A in 2023
Gather Health is an international healthcare technology company dedicated to empowering patients with chronic diseases to enhance their health. The company specializes in mobile and cloud-based healthcare applications that utilize the latest medical and behavioral change research to motivate and educate patients. By connecting physicians, patients, their families, and patient communities, Gather Health aims to provide continuous and holistic care, ultimately improving health outcomes. The rise in chronic diseases, such as obesity and diabetes, has created a demand for better care, which Gather Health addresses by equipping patients and healthcare providers with effective tools for managing these conditions. Their flagship product, the Gather Health Diabetes platform, has been successfully implemented in cities including Mumbai, Ahmedabad, Hyderabad, Chennai, and Bangalore, showing positive health outcomes for patients and increased efficiency for healthcare providers. Headquartered in Hong Kong, with offices in Beijing, New York, and India, Gather Health's team comprises clinicians, health experts, interaction designers, and engineers experienced in global healthcare.
Zus Health
Series A in 2023
Zus Health is a healthcare technology company founded in 2020 in Watertown, Massachusetts, by Jonathan Bush. The company develops a healthcare data platform aimed at accelerating digital health initiatives. Its platform uniquely integrates health and non-health data, offering a comprehensive view of patients while facilitating the sharing of clinical and non-clinical information across different applications. This approach empowers healthcare professionals to create customized digital technologies and services that are more affordable and accessible, addressing the common barriers in the healthcare sector. Zus Health is focused on fostering innovation among a new generation of healthcare builders, striving to enhance the overall health experience.
Oops
Seed Round in 2022
Oops is a venture-backed startup that offers easy returns right from your doorstep. The company helps individuals in packing, taping, labeling, driving, and making returns. Oops was founded in 2022 and is based in Salt Lake City, Utah.
Infleqtion
Series B in 2022
Infleqtion specializes in quantum technology, providing high-value information processing and solutions that enhance global communication security and efficiency. The company, with offices in the United States, United Kingdom, and Australia, leverages over 17 years of foundational research from ColdQuanta to deliver software-configured, quantum-enabled products that operate at the Edge. These products focus on critical applications such as positioning, navigation, timing, and resilient energy distribution, while also facilitating accelerated quantum computing. Infleqtion serves a diverse clientele, including commercial organizations and government entities, helping them to harness the power of quantum technology for innovation and development.
CareHarmony
Series A in 2022
CareHarmony, LLC, established in 2015 and based in Brentwood, Tennessee, specializes in whole-person care coordination services, focusing on Chronic Care Management. The company provides healthcare providers, including physician practices, Accountable Care Organizations (ACOs), and Independent Practice Associations (IPAs), with a comprehensive platform designed to enhance patient experience and clinical outcomes. CareHarmony's offerings include 24/7 patient access, mobile application support, customized patient care plans, secure file sharing, and streamlined billing assistance for Chronic Care Management. By integrating high-tech solutions with compassionate care, CareHarmony enables healthcare providers to adopt a limited-risk approach to value-based care.
Carta Healthcare
Series B in 2022
Carta Healthcare, Inc. is a technology company that provides a software-as-a-service platform designed to improve patient care in hospitals. Founded in 2016 and headquartered in San Mateo, California, the platform leverages existing IT data to describe patient journeys and predict potential bottlenecks, such as recovery bed shortages and cancellations. By employing machine learning, Carta Healthcare enables hospitals to personalize care, allowing them to identify past patients with similar profiles and analyze their experiences. This approach enhances the efficiency and quality of healthcare data management by combining artificial intelligence with skilled human expertise, facilitating more effective and cost-efficient data abstraction for health systems.
Areteia Therapeutics
Series A in 2022
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication of improving lung function and is found in several asthma-related treatments.
Proximie
Series C in 2022
Proximie Inc. is a health technology company based in Bedford, Massachusetts, that specializes in a telehealth platform designed for virtual surgical assistance. Founded in 2016 by Nadine Hachach-Haram, Proximie's platform enables surgeons to remotely observe and guide complex surgical procedures using augmented reality, artificial intelligence, and machine learning. This technology allows expert surgeons to connect with their peers globally, sharing knowledge and skills in real-time, regardless of their physical location. The platform is adaptable, compatible with various devices and software used in operating rooms, and can function effectively even in low bandwidth environments. Proximie aims to enhance surgical practices by democratizing access to expert guidance and fostering collaboration among medical professionals.
Coherent
Series B in 2022
Coherent transforms businesses, starting with a single cell. We unify developers and non-developers to redefine how business and IT teams work together. We transform spreadsheets into APIs, end-users into developers, and risk into control.
D-ID
Series B in 2022
D-ID is a software development company specializing in face recognition technologies and artificial intelligence solutions. Founded in 2016 and headquartered in Palo Alto, California, with an additional office in Tel Aviv, Israel, D-ID provides a range of products including de-identification software that enhances identity theft protection and ensures compliance with regulations by removing sensitive biometric data from facial images. The company also offers API, reality studio, and portrait products that utilize AI to create talking avatars and videos, catering to sectors such as marketing, e-learning, corporate training, and content creation. D-ID's technology aims to facilitate seamless interactions through natural conversation and to enhance user experiences across various applications.
PrognomiQ
Venture Round in 2022
PrognomiQ is a technology company dedicated to advancing early disease detection and treatment, particularly for cancer and other complex diseases. By harnessing multi-omics data, including proteomic, genomic, and metabolomic information, the company aims to enhance understanding and management of health conditions. PrognomiQ's innovative approach allows for the development of advanced medical test products that improve diagnostic capabilities and recurrence monitoring, ultimately seeking to enhance patient outcomes. Through its focus on integrating diverse health data, PrognomiQ is committed to transforming how medical practitioners approach disease detection and treatment.
Volta Labs
Series A in 2022
Volta Labs, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018. The company specializes in developing tools for biological automation, focusing on scalable automation solutions for genetic engineering. Volta Labs operates a platform designed for affordable genomic sample preparation, aimed at revolutionizing genomics research. This platform leverages automation and miniaturization technologies to streamline the creation of biological samples. By integrating expertise from engineering, surface chemistry, and molecular biology, Volta Labs enables biotech organizations to automate complex biological workflows, facilitating advancements in genomics and genetic engineering.
FitOn
Series C in 2022
FitOn Inc. is a fitness technology company based in Los Angeles, California, that offers an application designed for users to engage in live and on-demand workouts without the need for equipment. The FitOn app features a diverse range of classes, including yoga, Pilates, interval training, cardio, and dance, led by world-class trainers and celebrities. With over 12 million members who have collectively logged more than 1 billion workout minutes, FitOn promotes social interaction by allowing users to invite friends and communicate while exercising. Additionally, the company provides features such as calorie tracking, heart rate monitoring, and the ability to share progress and photos. FitOn Health, the company's enterprise service, collaborates with over 13,000 employers and major health plans in the U.S. to deliver specialized programs for individuals managing chronic health conditions. Incorporated in 2018, FitOn aims to empower users to maintain their fitness goals conveniently and effectively.
Lusix
Private Equity Round in 2022
Lusix grows and produces lab-grown diamonds for the gemstone market and various industrial applications.
Dewpoint Therapeutics
Series C in 2022
Dewpoint Therapeutics is a Boston-based biotech company focused on the research and development of treatments targeting biomolecular condensates to address various diseases, including cancer, neurodegenerative disorders, and immunological conditions. Founded in 2018, the company employs an innovative drug platform that utilizes machine-learning-based image analysis for visualizing condensates. This technology supports an engine of engineered cell lines designed to track and mitigate harmful protein sequestration. By leveraging its proprietary platform, Dewpoint seeks to facilitate drug discovery across a wide range of medical indications and collaborates with leading academic and pharmaceutical partners to enhance the accessibility of new therapies for unmet healthcare needs.
Clari
Series F in 2022
Clari Inc. operates a revenue operations platform that enhances efficiency and predictability in the sales process through automation and artificial intelligence. Founded in 2012 and based in Sunnyvale, California, the platform integrates data from various business systems, such as CRM, email, and marketing automation, to provide sales professionals with real-time insights into deal progress and activity. By organizing critical information around accounts and opportunities, Clari enables sales teams to make informed decisions, optimize their strategies, and effectively manage pipelines. The platform also includes predictive analytics capabilities that allow organizations to forecast revenue and reduce churn. Clari's services are utilized by numerous B2B companies, including notable firms like Qualtrics and Adobe, to streamline their revenue operations and improve overall business outcomes.
Belong Health
Series A in 2021
Belong Health works with local health plans to provide regionally informed, humanistic care to a rapidly expanding community of need.
Heap
Series D in 2021
Heap automates away the annoying parts of analytics so that companies can focus on making smarter business decisions. The company's mission is to power business decisions with truth. It encourages companies to focus on discovering insights and taking action. With Heap, organizations can remove technical jams and obtain a single comprehensive view of the customers. The software automatically gathers, organizes, analyzes, and connects customer data, so businesses can create more valuable products and experiences. Heap serves over 6,000 companies in ecommerce, SaaS, fintech, retail, media, and beyond including Twilio, LendingClub, App Annie, Optimizely, Morningstar, Monotype, and Casper. Heap was founded on 2013 and is headquartered in San Francisco, California.
Conveyor
Seed Round in 2021
Conveyor is a leading platform that utilizes generative AI to streamline and automate customer security reviews, addressing a significant pain point in the sales process. By providing an end-to-end solution that includes a customer-facing trust portal, a GPT-powered tool for responding to questionnaires, and a comprehensive service for questionnaire completion, Conveyor enables vendors to enhance trust with their customers. This innovative approach significantly reduces the time spent on the tedious task of sharing security information and answering security questionnaires by over 90%. Trusted by top SaaS companies, Conveyor aims to simplify the security review process, allowing information security teams to focus on more strategic tasks.
FitOn
Series B in 2021
FitOn Inc. is a fitness technology company based in Los Angeles, California, that offers an application designed for users to engage in live and on-demand workouts without the need for equipment. The FitOn app features a diverse range of classes, including yoga, Pilates, interval training, cardio, and dance, led by world-class trainers and celebrities. With over 12 million members who have collectively logged more than 1 billion workout minutes, FitOn promotes social interaction by allowing users to invite friends and communicate while exercising. Additionally, the company provides features such as calorie tracking, heart rate monitoring, and the ability to share progress and photos. FitOn Health, the company's enterprise service, collaborates with over 13,000 employers and major health plans in the U.S. to deliver specialized programs for individuals managing chronic health conditions. Incorporated in 2018, FitOn aims to empower users to maintain their fitness goals conveniently and effectively.
Devoted
Series D in 2021
Devoted Health is a healthcare company focused on enhancing the health and well-being of older Americans by treating each individual with care and compassion. The company offers an integrated healthcare solution that includes Medicare Advantage plans, access to local providers, and the option for virtual and in-home care through Devoted Medical. Their approach includes personalized medical plans and dedicated guides who work closely with physicians to streamline care and minimize unnecessary procedures. By leveraging advanced technology and a robust network of healthcare professionals, Devoted Health aims to provide high-quality, tailored healthcare services to its members.
Centivo
Venture Round in 2021
Centivo is a new type of health plan administrator that allows self-funded employers and clinicians to join forces and deliver high quality, affordable healthcare to their employees. An alternative to traditional insurance carriers or third-party administrators, Centivo offers the technology, network, claims processing, customer support, and population health management to fully administer health benefits for all or a portion of an employee population. The Centivo model emphasizes the partnership between individuals and their primary care team as the proper model to coordinate healthcare needs. Centivo’s clinical partners are dedicated to controlling costs and helping members navigate the healthcare system, aided by personalized patient/doctor matching tools. Members are rewarded for working with their primary care team and choosing high-value care and are supported through a user-friendly app and their concierge. Employers get an ally that diligently roots out waste and is accountable for performance. It was formed in 2017 and headquartered in New York, United States.
Chapter
Series A in 2021
Chapter operates a Medicare navigation platform designed to assist seniors in selecting appropriate health coverage. The platform provides advisory services that ensure consumers receive the best coverage options tailored to their individual needs at the most affordable prices. By aligning the incentives of Medicare advisors and consumers, Chapter promotes unbiased recommendations that consider all available options, free from economic conflicts of interest. Additionally, the company offers retirees personalized resources such as tailored coupons, tax advice, and technology tips, enhancing their ability to live securely and purposefully as they age.
House Rx
Seed Round in 2021
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.
CCC Intelligent Solutions
Post in 2021
CCC Intelligent Solutions is a provider of cloud-based software and technology solutions for the property and casualty insurance industry. Its platform connects over 30,000 businesses, including insurers, repairers, automakers, and part suppliers, facilitating commerce and supporting critical digital workflows. The company specializes in artificial intelligence, telematics, and mobile applications, enabling efficient operations and enhanced customer experiences. CCC generates revenue primarily through software subscriptions and professional services, with a significant portion coming from the United States, as well as a presence in China. By leveraging innovative technologies, CCC aims to streamline processes and improve outcomes in the insurance sector.
Zus Health
Series A in 2021
Zus Health is a healthcare technology company founded in 2020 in Watertown, Massachusetts, by Jonathan Bush. The company develops a healthcare data platform aimed at accelerating digital health initiatives. Its platform uniquely integrates health and non-health data, offering a comprehensive view of patients while facilitating the sharing of clinical and non-clinical information across different applications. This approach empowers healthcare professionals to create customized digital technologies and services that are more affordable and accessible, addressing the common barriers in the healthcare sector. Zus Health is focused on fostering innovation among a new generation of healthcare builders, striving to enhance the overall health experience.
Fractyl Health
Series F in 2021
Fractyl Health, based in Lexington, Massachusetts, specializes in developing innovative medical device solutions for metabolic diseases, particularly type 2 diabetes and obesity. The company’s primary offering, Revita DMR, is a minimally invasive therapy that utilizes hydrothermal ablation to rejuvenate the duodenal lining, which can become compromised due to high-fat and high-sugar diets. By focusing on durable disease-modifying therapies rather than just symptomatic management, Fractyl Health aims to address the underlying causes of metabolic diseases, improving patient outcomes and reducing healthcare burdens. Founded in 2010 and originally named MedCatalyst, Inc., the company envisions a future where less invasive, device-based therapies provide effective solutions for large populations affected by metabolic disorders.
CareMax
Post in 2021
CareMax is a technology-enabled care platform focused on delivering value-based care and chronic disease management for seniors. The company operates a network of medical centers that provide a wide range of healthcare and social services. In addition to its medical facilities, CareMax offers a proprietary software and services platform designed to equip physicians with data, analytics, and decision-making tools. This integrated approach aims to enhance patient outcomes and streamline healthcare delivery across the United States.
Cano Health
Post in 2021
Cano Health is a healthcare company focused on providing personalized, value-based primary care services primarily for seniors. Operating across Florida, Texas, Nevada, and Puerto Rico, Cano Health manages primary care centers and supports affiliated medical practices. The company emphasizes high-touch population health management through a comprehensive care coordination strategy that includes wellness activities, pharmacy services, home visits, telehealth, and management of high-risk and complex cases. Serving approximately 310,000 members, Cano Health aims to enhance health outcomes, wellness, and quality of life for its patients and the communities it operates in.
QuintoAndar
Series E in 2021
QuintoAndar is a digital platform that streamlines the rental process for residential real estate in Brazil. Founded in February 2013 by Gabriel Braga and Andre Penha, and headquartered in São Paulo, the company provides a marketplace where users can access rental listings, schedule property visits, and finalize rental agreements without the need for extensive paperwork. QuintoAndar enhances the experience for both landlords and tenants by offering features such as rental insurance and automated payment processing, which eliminate the requirement for guarantors. This approach fosters a practical, transparent, and efficient rental experience, making it easier for individuals to navigate the real estate market.
SnapDocs
Series D in 2021
Snapdocs, Inc. is a real estate technology firm based in San Francisco that specializes in creating a digital platform for mortgage closings. Founded in 2013, Snapdocs connects lenders, title companies, and notary signing agents to enhance the efficiency and accuracy of the closing process. The platform automates interactions and workflows, allowing for streamlined operations and improved customer experiences. It offers features that enable lenders to adopt digital closings, providing flexibility in closing types, while also allowing title and escrow clients to automate their workflows. Notary signing agents can showcase their qualifications, and home buyers gain early access to their closing packages, fostering a smoother transaction. By leveraging advanced automation and AI technology, Snapdocs aims to simplify the complexities of mortgage closings, ultimately saving time and reducing costs for all participants involved.
Mon Ami
Seed Round in 2021
Mon Ami, Inc. is a California-based company founded in 2018 that has developed an application aimed at connecting college students with seniors who experience social isolation due to conditions such as dementia, Alzheimer’s, Parkinson’s disease, autism, and cancer. The platform facilitates meetings between seniors and companions or families, addressing the growing need for social connectivity among older adults. Additionally, Mon Ami offers software solutions tailored for aging and disability service providers, allowing them to enhance their operational efficiency and reduce administrative burdens. These tools are designed to be HIPAA compliant, enabling service providers to streamline workflows, increase their capacity to assist more seniors, and effectively track outcomes related to senior well-being. Through these initiatives, Mon Ami seeks to address challenges in the senior services market and improve the quality of life for older adults.
Proximie
Series B in 2021
Proximie Inc. is a health technology company based in Bedford, Massachusetts, that specializes in a telehealth platform designed for virtual surgical assistance. Founded in 2016 by Nadine Hachach-Haram, Proximie's platform enables surgeons to remotely observe and guide complex surgical procedures using augmented reality, artificial intelligence, and machine learning. This technology allows expert surgeons to connect with their peers globally, sharing knowledge and skills in real-time, regardless of their physical location. The platform is adaptable, compatible with various devices and software used in operating rooms, and can function effectively even in low bandwidth environments. Proximie aims to enhance surgical practices by democratizing access to expert guidance and fostering collaboration among medical professionals.
Carta Healthcare
Series A in 2021
Carta Healthcare, Inc. is a technology company that provides a software-as-a-service platform designed to improve patient care in hospitals. Founded in 2016 and headquartered in San Mateo, California, the platform leverages existing IT data to describe patient journeys and predict potential bottlenecks, such as recovery bed shortages and cancellations. By employing machine learning, Carta Healthcare enables hospitals to personalize care, allowing them to identify past patients with similar profiles and analyze their experiences. This approach enhances the efficiency and quality of healthcare data management by combining artificial intelligence with skilled human expertise, facilitating more effective and cost-efficient data abstraction for health systems.
KUDO
Series A in 2021
KUDO, Inc., also known as Kudo Technologies, specializes in a language as a service (LaaS) platform designed for multilingual online meetings. Founded in 2016 and headquartered in New York, KUDO provides a cloud-based software as a service (SaaS) that facilitates video conferencing and chatting with integrated support for interpreters and multiple audio streams. The platform enables businesses to conduct multilingual live events and offers tools for web conferencing and language-ready rooms. KUDO's solutions allow teams to communicate effectively across global markets, ensuring that participants and interpreters can connect from anywhere using standard computers or smartphones.
Cylera
Series A in 2021
Cylera, Inc. is a cybersecurity company focused on protecting healthcare organizations from cyber threats and malware. Founded in 2017 and headquartered in New York, Cylera offers a comprehensive platform that utilizes patented technology to provide unified cybersecurity solutions. Their software specializes in asset management, risk analysis, and threat detection, specifically designed for the healthcare Internet of Things (IoT) environment. By identifying all connected devices, analyzing vulnerabilities, and mitigating threats in real time, Cylera enables healthcare providers and other organizations to effectively manage risks and respond automatically to potential security incidents.
Caribou Biosciences
Series C in 2021
Caribou Biosciences, Inc. is a biotechnology company focused on cellular engineering and genome editing using CRISPR technology. Established in 2011 and based in Berkeley, California, the company leverages its CRISPR-Cas gene editing platform to facilitate precise modifications in DNA across various applications. These include developing therapeutics for human and animal health, creating disease models, enhancing agricultural traits, and advancing industrial biotechnology. Caribou Biosciences is particularly dedicated to the development of genome-edited cell therapies, including allogeneic CAR-T and CAR-NK cell therapies, aimed at improving outcomes for patients with severe diseases. The company’s innovative approach combines CRISPR with guide RNA to enable targeted DNA alterations, thereby contributing to advancements in both therapeutic development and biological research.
Garner Health
Series A in 2021
Garner Health is a provider of healthcare services used to help employers give their employees a better healthcare experience. The company offers its solution through employers who want to give their employees a better quality healthcare experience and in-turn save on the cost of healthcare because the best doctors end up costing the least money. Garner Health was founded in 2019 and is headquartered in New York.
Centivo
Series B in 2020
Centivo is a new type of health plan administrator that allows self-funded employers and clinicians to join forces and deliver high quality, affordable healthcare to their employees. An alternative to traditional insurance carriers or third-party administrators, Centivo offers the technology, network, claims processing, customer support, and population health management to fully administer health benefits for all or a portion of an employee population. The Centivo model emphasizes the partnership between individuals and their primary care team as the proper model to coordinate healthcare needs. Centivo’s clinical partners are dedicated to controlling costs and helping members navigate the healthcare system, aided by personalized patient/doctor matching tools. Members are rewarded for working with their primary care team and choosing high-value care and are supported through a user-friendly app and their concierge. Employers get an ally that diligently roots out waste and is accountable for performance. It was formed in 2017 and headquartered in New York, United States.
Dewpoint Therapeutics
Series B in 2020
Dewpoint Therapeutics is a Boston-based biotech company focused on the research and development of treatments targeting biomolecular condensates to address various diseases, including cancer, neurodegenerative disorders, and immunological conditions. Founded in 2018, the company employs an innovative drug platform that utilizes machine-learning-based image analysis for visualizing condensates. This technology supports an engine of engineered cell lines designed to track and mitigate harmful protein sequestration. By leveraging its proprietary platform, Dewpoint seeks to facilitate drug discovery across a wide range of medical indications and collaborates with leading academic and pharmaceutical partners to enhance the accessibility of new therapies for unmet healthcare needs.
Galecto
Series D in 2020
Galecto is a clinical-stage biotechnology company focused on developing small molecules to treat severe diseases, particularly fibrosis and cancer. The company’s lead product candidate, GB0139, is an inhaled inhibitor of galectin-3 aimed at addressing severe fibrotic lung diseases, including idiopathic pulmonary fibrosis, which presents a significant unmet medical need. Founded in 2011, Galecto builds upon more than a decade of research into the roles of galectin-3 and lysyl oxidase-like 2 (LOXL2) in fibrotic diseases. The company also develops additional therapeutics, such as GB1211, a selective oral galectin-3 inhibitor targeting fibrosis related to non-alcoholic steatohepatitis. Galecto's strong patent portfolio and research foundation position it uniquely within the therapeutic landscape for fibrosis and related diseases.
PrognomiQ
Venture Round in 2020
PrognomiQ is a technology company dedicated to advancing early disease detection and treatment, particularly for cancer and other complex diseases. By harnessing multi-omics data, including proteomic, genomic, and metabolomic information, the company aims to enhance understanding and management of health conditions. PrognomiQ's innovative approach allows for the development of advanced medical test products that improve diagnostic capabilities and recurrence monitoring, ultimately seeking to enhance patient outcomes. Through its focus on integrating diverse health data, PrognomiQ is committed to transforming how medical practitioners approach disease detection and treatment.
Orasis Pharmaceuticals
Series C in 2020
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia. The company's product, CSF-1, is an eye drop that improves the quality of life for people with presbyopia by alleviating the burden of reading glasses. By repurposing existing and well-studied molecules, CSF-1 is designed to be effective and also safe, comfortable, and easy-to-use.
Decent
Series A in 2020
Decent Inc. is a company that specializes in providing health and medical insurance plans tailored for self-employed professionals. Founded in 2018 and based in Mill Valley, California, Decent offers plans such as the Trailblazer Plan, which is designed to meet the comprehensive health needs of freelance workers. The company focuses on delivering more affordable healthcare by aligning incentives that promote better health outcomes, reduce overall costs, and prioritize the needs of its members in the healthcare process.
Octopai
Series A in 2020
Octopai is an Automated Data Intelligence platform that assists data teams in managing complex data landscapes. The platform provides multilayered data lineage, data discovery, and a comprehensive data catalog, facilitating the tracking of data assets and understanding of data flow within organizations. By offering a no-code solution, Octopai helps businesses streamline their data operations, allowing for easier access to vital information and the ability to trust their data resources. This approach effectively addresses organizational data challenges and enhances overall data management efficiency.
Seer
Series D in 2020
Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases. The company's platform captures and translates molecular insights from the proteome with improved accuracy and speed, enabling healthcare professionals to detect cancer and neurological diseases, drive earlier treatment and improve patient outcomes.
Cityblock
Series B in 2020
Cityblock Health is a technology-driven provider focused on meeting the complex health and social needs of Medicaid and Medicare populations. The company delivers a personalized health system that integrates primary care, behavioral health, and social services, partnering with community-based organizations to ensure tailored support for each member. By investing in prevention-oriented care and utilizing technology to enhance coordination and communication, Cityblock aims to improve health outcomes while reducing costs. During the COVID-19 pandemic, the organization developed a model to identify members at high risk, demonstrating its commitment to addressing urgent health challenges within communities.
Behalf
Series D in 2020
Behalf, Inc. is a financing provider headquartered in New York, with an additional office in Tel Aviv, Israel. Founded in 2011, the company facilitates commerce between B2B merchants and their business customers by offering automated payment solutions that include instant credit and flexible payment terms at the point of sale. Behalf integrates seamlessly into merchants' sales and invoicing processes, allowing for access to financing regardless of the invoice or transaction size. By paying merchants upfront, Behalf enhances sales and improves cash flow for both merchants and their business customers. The company focuses on providing short-term financing to small businesses, enabling them to efficiently manage payments to suppliers while increasing operational effectiveness through automation.
D-ID
Series A in 2020
D-ID is a software development company specializing in face recognition technologies and artificial intelligence solutions. Founded in 2016 and headquartered in Palo Alto, California, with an additional office in Tel Aviv, Israel, D-ID provides a range of products including de-identification software that enhances identity theft protection and ensures compliance with regulations by removing sensitive biometric data from facial images. The company also offers API, reality studio, and portrait products that utilize AI to create talking avatars and videos, catering to sectors such as marketing, e-learning, corporate training, and content creation. D-ID's technology aims to facilitate seamless interactions through natural conversation and to enhance user experiences across various applications.
Revuze
Series A in 2020
Revuze specializes in Generative AI analysis of online reviews, transforming how businesses gather consumer insights. The company provides cloud-based software that automates the analysis of customer reviews and unstructured data, allowing clients to derive valuable insights into customer experiences and competitive positioning. Its solutions facilitate the integration of review analytics into marketing and product strategies, supporting informed decision-making. Revuze offers real-time analysis through user-friendly features such as dynamic dashboards and comprehensive reports, enabling businesses to navigate the evolving market landscape effectively. By leveraging high-quality data and insightful predictions, Revuze helps organizations understand their customers and competitors more deeply, ensuring they can make data-driven decisions with confidence.
Bounce
Series D in 2020
Bounce (formerly known as Metro Bikes) is a smart mobility solution, with a mission of making daily commute stress-free, time-saving, reliable, and convenient. With a breakthrough technology that lets users access the bike with just an OTP, the Keyless bikes, have not only done away with keys, but the whole process of renting a bike has just become devoid of any physical or human intervention. With Bounce's new One Way Rental service, users can now pick up and drop the bike anywhere they need to and be done with the ride. This is aimed at providing a seamless first mile and last-mile connectivity to metro users. Founded in 2014, Bounce aims at decongesting the roads by encouraging commuters to choose public transport by delivering convenient options to rent bikes and reach their destinations from metro stations. It is based in Bangalore, India.
Seer
Series D in 2019
Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases. The company's platform captures and translates molecular insights from the proteome with improved accuracy and speed, enabling healthcare professionals to detect cancer and neurological diseases, drive earlier treatment and improve patient outcomes.
Infleqtion
Seed Round in 2019
Infleqtion specializes in quantum technology, providing high-value information processing and solutions that enhance global communication security and efficiency. The company, with offices in the United States, United Kingdom, and Australia, leverages over 17 years of foundational research from ColdQuanta to deliver software-configured, quantum-enabled products that operate at the Edge. These products focus on critical applications such as positioning, navigation, timing, and resilient energy distribution, while also facilitating accelerated quantum computing. Infleqtion serves a diverse clientele, including commercial organizations and government entities, helping them to harness the power of quantum technology for innovation and development.
Remrise
Seed Round in 2019
Remrise is a health, wellness, and fitness company that specializes in manufacturing plant-powered sleep formulas and tools to help its clients improve their sleep. It provides an online marketplace that allows people to purchase organic sleeping supplements online. The company was founded in 2018 and headquartered in San Francisco, California.
Bungalow
Series B in 2019
Bungalow is a residential real estate platform that facilitates flexible and communal living arrangements for renters, particularly targeting early career professionals. Founded in 2016 by Andrew Collins and Justin McCarty, the company is headquartered in San Francisco, California. Bungalow signs long-term leases with homeowners to offer multi-bedroom homes in desirable urban neighborhoods across the United States. Each property features private bedrooms with handpicked housemates, and comes fully furnished with essential amenities such as Wi-Fi, utilities, and housekeeping. Additionally, Bungalow organizes monthly community events to foster social interaction among residents. By addressing the needs of modern renters, Bungalow provides a convenient solution for those seeking quality living environments while cultivating a sense of community.
Science Exchange
Venture Round in 2019
Science Exchange, Inc. operates an online marketplace that facilitates collaboration between researchers and academic or government laboratories. Established in 2011 and based in Palo Alto, California, the platform allows researchers to search for scientific services from U.S. research institutions, compare pricing, and access quality testimonials. It streamlines the outsourcing process by automating tasks such as obtaining quotes, managing projects, and processing payments, while ensuring data security and regulatory compliance. The marketplace enhances research and development productivity by connecting scientists who need experiments conducted with those who can perform them, thereby providing affordable access to outsourced R&D services. Additionally, Science Exchange offers an enterprise dynamic report tool for pharmaceutical and biotech companies to track key performance indicators related to their outsourced research investments.
Science Exchange
Debt Financing in 2019
Science Exchange, Inc. operates an online marketplace that facilitates collaboration between researchers and academic or government laboratories. Established in 2011 and based in Palo Alto, California, the platform allows researchers to search for scientific services from U.S. research institutions, compare pricing, and access quality testimonials. It streamlines the outsourcing process by automating tasks such as obtaining quotes, managing projects, and processing payments, while ensuring data security and regulatory compliance. The marketplace enhances research and development productivity by connecting scientists who need experiments conducted with those who can perform them, thereby providing affordable access to outsourced R&D services. Additionally, Science Exchange offers an enterprise dynamic report tool for pharmaceutical and biotech companies to track key performance indicators related to their outsourced research investments.
Heap
Series C in 2019
Heap automates away the annoying parts of analytics so that companies can focus on making smarter business decisions. The company's mission is to power business decisions with truth. It encourages companies to focus on discovering insights and taking action. With Heap, organizations can remove technical jams and obtain a single comprehensive view of the customers. The software automatically gathers, organizes, analyzes, and connects customer data, so businesses can create more valuable products and experiences. Heap serves over 6,000 companies in ecommerce, SaaS, fintech, retail, media, and beyond including Twilio, LendingClub, App Annie, Optimizely, Morningstar, Monotype, and Casper. Heap was founded on 2013 and is headquartered in San Francisco, California.
Seer
Series C in 2019
Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases. The company's platform captures and translates molecular insights from the proteome with improved accuracy and speed, enabling healthcare professionals to detect cancer and neurological diseases, drive earlier treatment and improve patient outcomes.
1mg
Series D in 2019
1mg is a digital consumer healthcare platform based in Gurgaon, Haryana, India, that aims to make healthcare more accessible, understandable, and affordable. Launched in 2015, it allows users to find detailed information about medicines prescribed by doctors and purchase them directly. The platform enables users to search for drugs based on ailments, classes, companies, and brands. Additionally, 1mg offers a service that helps consumers find the right healthcare professionals tailored to their needs. Its diagnostics service enhances transparency and cost-effectiveness in lab tests, empowering Indian consumers and caregivers to choose appropriate healthcare services at competitive prices.
Bounce
Series C in 2019
Bounce (formerly known as Metro Bikes) is a smart mobility solution, with a mission of making daily commute stress-free, time-saving, reliable, and convenient. With a breakthrough technology that lets users access the bike with just an OTP, the Keyless bikes, have not only done away with keys, but the whole process of renting a bike has just become devoid of any physical or human intervention. With Bounce's new One Way Rental service, users can now pick up and drop the bike anywhere they need to and be done with the ride. This is aimed at providing a seamless first mile and last-mile connectivity to metro users. Founded in 2014, Bounce aims at decongesting the roads by encouraging commuters to choose public transport by delivering convenient options to rent bikes and reach their destinations from metro stations. It is based in Bangalore, India.
Collective Health
Series E in 2019
Collective Health is a prominent health benefits platform that streamlines the management of medical, dental, vision, and pharmacy services for employees and their families. By offering an integrated solution through a cloud-based self-insurance platform, the company simplifies the administration of health plans via a single portal. This platform provides users with clear guidance, live concierge support, and digital tools to facilitate the navigation and management of healthcare services. Collective Health aims to reduce the complexities of delivering health benefits, enhance the member experience, and promote healthier outcomes for both employees and organizations. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.